<< Back to News

System Formulary Update
​​Belantamab mafodotin-blmf (Blenrep) 70 g SDV
April 21, 2026

Situation 

Belantamab mafodotin-blmf (Blenrep) 70 mg for injection was approved for addition to the UNC Health system formulary at the March 2026 System Pharmacy and Therapeutics Committee meeting. 

Background 

The following medication was reviewed: Belantamab mafodotin-blmf 70 mg for injection 

Assessment/Recommendation 

Change effective: Tuesday, April 21st    

System P&T voted to include the following products on the UNC Health Medication Formulary: 

• Belantamab mafodotin-blmf 70 mg for injection 

Note: Stock of this formulary product may vary at individual entities